Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MILWAUKEE, Wis., March 3, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Best known as the co-author of "Freakonomics," and "SuperFreakonomics," Stephen Dubner is one of five keynote speakers -- four of whom...
-
CAMBRIDGE, Mass., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
-
MIAMI, FL--(Marketwired - February 24, 2016) - The winners of the Clinical Informatics News Best Practices Awards were announced on Wednesday at the Summit for Clinical Ops Executives, SCOPE, in...
-
NEEDHAM, MA--(Marketwired - February 12, 2016) - Cambridge Healthtech Institute, a leading provider of life science conferences, is pleased to offer pharma, biotech, healthcare and technology...
-
NEEDHAM, MA--(Marketwired - February 04, 2016) - Barnett International, a division of Cambridge Healthtech Institute, announced today that Liz Wool joined its senior management team. In her new...
-
NEEDHAM, MA--(Marketwired - February 04, 2016) - Clinical Informatics News today announced ten finalists in its 2016 Best Practices Awards. Three of the finalists will be named winners at SCOPE,...
-
12- month primary endpoint not met in the overall populationStatistical difference in viral clearance rates in 2 predefined key subgroups DSMB recommends continuation of the study per protocol18-month...
-
BOSTON, MA--(Marketwired - January 13, 2016) - Cambridge Healthtech Institute, a leading provider of healthcare, technology and life science conferences, and Clinical Informatics News, an online...
-
Ordinary shares currently are listed on NASDAQ and will be listed on the Tel Aviv Stock Exchange (TASE) beginning January 12, 2016 under ticker symbol ABIL NEW YORK and TEL AVIV, Israel, Jan. 08,...
-
Dimension Therapeutics Announces Expansion of Internal Research and Process Development Capabilities
CAMBRIDGE, Mass., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases,...